|1.||Chen, Hsing I: 5 articles (01/2012 - 05/2003)|
|2.||Huang, Kun-Lun: 3 articles (12/2013 - 04/2008)|
|3.||Chu, Shi-Jye: 3 articles (12/2013 - 08/2004)|
|4.||Park, Nam Gyu: 3 articles (01/2009 - 08/2007)|
|5.||Khan, Mohammed Nurul Absar: 3 articles (01/2009 - 08/2007)|
|6.||Hong, Yong-Ki: 3 articles (01/2009 - 08/2007)|
|7.||Fujii, Hitoshi: 3 articles (07/2008 - 08/2007)|
|8.||Hsu, Kang: 3 articles (08/2004 - 05/2003)|
|9.||Wang, David: 3 articles (08/2004 - 05/2003)|
|10.||Sambandam, Sumitha A T: 2 articles (06/2015 - 12/2011)|
06/01/1983 - "Prolonged contact with nanomole to micromole concentrations of the tumor promoter phorbol myristate acetate causes a significant reduction in the lytic activity of cloned cytolytic T cells. "
12/01/1992 - "In the present study we investigated the in vitro effects of the tumor promoter phorbol myristate acetate (PMA) on the accessory function of mouse spleen dendritic cells (DC) in mitogenesis. "
11/01/1976 - "Fluorescence studies on the interaction of the tumor promoter phorbol myristate acetate and related compounds with rat liver plasma membranes."
09/01/1973 - "Dose-response studies with a pure tumor-promoting agent, phorbol myristate acetate."
11/01/2015 - "Phorbol myristate acetate (PMA), as a potent tumor promoter, may induce microglial senescence. "
12/01/2012 - "Phorbol myristate acetate-stimulated oxidative burst in HD11 cells was greatly impaired after infection by each of the five serovars. "
03/01/2010 - "We found that the release of ectosomes was not associated exclusively with mycobacterial infection since infection with other microorganisms (e.g., Leishmania mexicana, Staphylococcus aureus, and Escherichia coli or activation with phorbol myristate acetate (PMA)) also induced ectocytosis. "
07/01/2001 - "However, the production of O2- by macrophages was undetectable during the first 30 min following infection and no respiratory burst was inducible by phorbol myristate acetate (PMA) 4 h after infection with V. anguillarum. "
06/01/2001 - "Ad/t-PA infection of phorbol myristate acetate (PMA)-differentiated MEG-01 cells increased cellular t-PA levels by 120 fold (1580 +/- 130 ng/10(6) cells at 5 MOI) in comparison to non-or Ad/beta-gal-infected cells. "
12/01/1998 - "To address this question, we evaluated Leishmania panamensis infection of (1) the human promonocytic/histiocytic cell line U-937 before and after induction of differentiation by phorbol myristate acetate; (2) fresh human peripheral blood monocytes; and (3) macrophages derived from monocytes by differentiation in vitro. "
|3.||Acute Lung Injury
01/01/2012 - "Phorbol myristate acetate (PMA) is a strong neutrophil activator and has been used to induce acute lung injury (ALI). "
07/01/2008 - "Phorbol myristate acetate (PMA) causes acute lung injury (ALI). "
02/01/1999 - "A model of acute lung injury induced by intravenous phorbol myristate acetate (PMA) is described. "
01/01/1999 - "Phorbol myristate acetate (PMA) activates neutrophils and causes acute lung injury. "
02/01/1998 - "We investigated the hypothesis that NO opposes increases in pulmonary vascular permeability after phorbol myristate acetate administration, i.e., in a model of neutrophil-dependent acute lung injury. "
05/01/1994 - "Human peritoneal MO from inflammation-free patients reacted against a human tumour cell line if cultured with LPS and TPA (phorbol-myristate acetate) and were therapeutically effective against the same palpable s.c. "
10/01/1995 - "The present study was designed to test the hypothesis that ileal microvascular injury during phorbol myristate acetate (PMA)-induced systemic inflammation is also blocked by MoAB 60.3. "
01/01/2015 - "Using phorbol-myristate-acetate as an activator of inflammation, we investigated the effect on the developing rodent brain. "
12/01/2010 - "The most active synthetic compound 33 reduced phorbol myristate acetate (PMA)-induced inflammation in the mouse ear by 72% at 50 μg/ear. "
11/04/2008 - "Topical application of phorbol myristate acetate (PMA) elicits intense local inflammation that facilitates outgrowth of premalignant lesions in skin after carcinogen exposure. "
10/01/1987 - "In a previous study, we demonstrated that a non-toxic concentration of phorbol myristate acetate (PMA) produced edema in isolated rat lungs which were coperfused with neutrophils (PMN). "
07/27/2012 - "The anti-inflammatory activity of 1-3 was evaluated by measuring their ability to reduce phorbol myristate acetate (PMA)-induced edema in a mouse ear model. "
08/11/2000 - "Mangicols A and B, however, showed significant antiinflammatory activity in the PMA (phorbol myristate acetate)-induced mouse ear edema model. "
06/01/1992 - "Hemodynamic changes, arterial oxygenation, and the development of lung edema were monitored for 4 hrs after phorbol myristate acetate injection to assess the extent of lung damage. "
01/01/1995 - "Phorbol-myristate acetate (PMA) is commonly used to produce experimental edema and other tissue injuries in the lung. "
|2.||Tretinoin (Retinoic Acid)
|4.||Arachidonic Acid (Vitamin F)
|6.||Reactive Oxygen Species (Oxygen Radicals)
|10.||Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)